Latest News in the pharma Industry

Market News

Demand for Aquila BioMedica's specialist CRO services accelerates company expansion

Demand for Aquila BioMedica's specialist CRO services accelerates company expansion

7 Sep 2016

Company's immuno-oncology and histology services have allowed clients' go/no-go decisions to be made earlier in the drug development process and ultimately reduce clinical attrition.

Read more 
OrthoSera receives CE Marking for hypACT device to regenerate osteoarthritic bone

OrthoSera receives CE Marking for hypACT device to regenerate osteoarthritic bone

7 Sep 2016

Patent and market authorization for human hyperacute serum product.

Read more 
BlueWind Medical receives CE Marking for its miniature implanted wireless stimulator to treat PNP

BlueWind Medical receives CE Marking for its miniature implanted wireless stimulator to treat PNP

7 Sep 2016

The BlueWind VIVENDI System is a wireless, battery-less neurostimulator which is 90% smaller than typical neurostimulators in the market.

Read more 
Non-drug device reduces COPD exacerbations - real-world study presented at ERS

Non-drug device reduces COPD exacerbations - real-world study presented at ERS

7 Sep 2016

The Aerobika device demonstrated a clinically-significant reduction in exacerbations in as little as 30 days of treatment, when used as an add-on to usual COPD medications.

Read more 
Apricus Biosciences launches its novel topical treatment for erectile dysfunction in Portugal, Ireland and Poland

Apricus Biosciences launches its novel topical treatment for erectile dysfunction in Portugal, Ireland and Poland

7 Sep 2016

To be Commercialized in Portugal and Ireland as Vitaros and in Poland as Vytaros.

Read more 
Ajaz Hussain and Wuxi Apptec’s Dr Minzhang Chen join 12 strong CPhI Annual Industry report experts

Ajaz Hussain and Wuxi Apptec’s Dr Minzhang Chen join 12 strong CPhI Annual Industry report experts

6 Sep 2016

2016 report topics include 3D printing, FDA quality metrics, contract services, pharma growth in China and India, and generic licensing.

Read more 
Avara acquires AstraZeneca UK manufacturing facility

Avara acquires AstraZeneca UK manufacturing facility

6 Sep 2016

The plant will continue to manufacture critical AstraZeneca pharmaceutical products on a contract basis.

Read more 
Aptar Pharma hosts “The Nasal drug Delivery Journey: From Systemic to Nose-to-Brain scientific webinar

Aptar Pharma hosts “The Nasal drug Delivery Journey: From Systemic to Nose-to-Brain" scientific webinar

6 Sep 2016

Webinar will focus on the nasal drug delivery route in the treatment of central nervous system diseases.

Read more 
Cambrex to expand large-scale API manufacturing at its Karlskoga facility in Sweden

Cambrex to expand large-scale API manufacturing at its Karlskoga facility in Sweden

6 Sep 2016

The investment includes the installation of new multi-purpose reactors and upgrading of the control room within an existing plant on site.

Read more 
Allergan adds first-in-class technology to its innovative eye care pipeline through acquisition

Allergan adds first-in-class technology to its innovative eye care pipeline through acquisition

6 Sep 2016

Acquisition of RetroSense Therapeutics adds global rights to RST-001, a novel gene therapy approach for the potential treatment of Retinitis Pigmentosa.

Read more 
Eppendorf striving to ensure all labs are smart, safe, and stress-free, with Eppendorf Advantage

Eppendorf striving to ensure all labs are smart, safe, and stress-free, with Eppendorf Advantage

5 Sep 2016

A range of best-in-class solutions that drive productivity in the laboratory.

Read more 
Alvogen launches first generic equivalent of Copaxone in Europe

Alvogen launches first generic equivalent of Copaxone in Europe

5 Sep 2016

First Generic and clinically validated product for Multiple Sclerosis in Europe.

Read more